Nevirapine recalls
The FDA has published 1 recall involving Nevirapine since 2018. The latest was reported on 26 Dec 2018. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 26 Dec 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why nevirapine is recalled
Companies
By year
All nevirapine recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nevirapine Extended Release Tablets, 400 mg recalled by Cipla | Cipla | Potency & Assay | Nationwide |
Should you stop taking Nevirapine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.